At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 484 enrolled
Drug / intervention
Serlopitant High Dose +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
In Brief
A Phase 2 clinical trial evaluating Serlopitant High Dose, Placebo Oral Tablet, and 1 other intervention for Pruritus and Atopic Dermatitis. Completed, enrolled 484 participants across 52 sites.
Detailed Summary
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPruritus, Atopic Dermatitis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartNov 2016
First PostedNov 2016
Primary CompletionJan 2018
Study CompletionFeb 2018
TodayJul 2026
First PostedNov 29, 2016
Enrollment StartNov 1, 2016
Primary CompletionJan 16, 2018
Study CompletionFeb 23, 2018
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.6 years ago
Interventions
Serlopitant High Dosedrug
serlopitant tablets - high dose
Placebo Oral Tabletdrug
placebo tablet
Serlopitant Low Dosedrug
serlopitant tablets - low dose